Pourya Gholizadeh | Immunology and Microbiology | Editorial Board Member

Published on by Academic Excellence

Editorial Board Member

Pourya Gholizadeh
Ardabil University of Medical Sciences,Iran

Pourya Gholizadeh
Affiliation Ardabil University of Medical Sciences
Country Iran
Google Scholar ID 1XSHxVkAAAAJ
Documents 110
Citations 4,556
h-index 37
Subject area Immunology and Microbiology
Event International Academic Excellence Awards

Pourya Gholizadeh is a researcher whose listed publications address antimicrobial resistance, microbial pathogenesis, oral microbiology, and the interactions between microorganisms and human health. His work, as represented by the publications supplied for this profile, connects microbiological mechanisms with clinically relevant questions, including antibiotic resistance and the potential contribution of oral bacteria to disease. This article summarizes selected research themes and publications and presents a profile for academic recognition through the International Academic Excellence Awards. The bibliographic details and research metrics should be checked against their original databases before formal publication.[1]

Abstract

This profile reviews selected research by Pourya Gholizadeh in immunology and microbiology. The supplied publication list highlights antibiotic resistance, the CRISPR-Cas system, oral microbial communities, and bacterial contributions to disease. These topics are relevant to infection prevention, antimicrobial stewardship, and the development of future research strategies. The profile uses the provided bibliographic records and metrics without independently verifying database totals or claiming that individual studies establish clinical effectiveness.

Keywords

Antimicrobial resistance; colistin resistance; Enterobacteriaceae; CRISPR-Cas; oral microbiome; microbial pathogenesis; oral cancer; immunology; microbiology; bacterial infection.

Introduction

Antimicrobial resistance is a major research concern because resistant microorganisms can complicate infection management and limit treatment options. In parallel, investigations of the oral microbiome examine how microbial communities interact with host tissues and how particular organisms may be associated with inflammatory conditions and cancer. Gholizadeh’s listed publications address both areas, providing a basis for examining links between microbiological mechanisms and human health.[2]

Research Profile

The supplied records indicate a research portfolio spanning reviews, mechanistic investigations, and discussions of emerging antimicrobial technologies. Its interdisciplinary character is reflected in the relationship between microbial genetics, clinical microbiology, oral health, and infection research. The stated institutional affiliation is Ardabil University of Medical Sciences, Iran. A verified Scopus identifier and ORCID have not been supplied and should be added only after confirmation.

Research Contributions

One prominent theme is colistin resistance in Enterobacteriaceae, a subject relevant to the study of treatment options for difficult bacterial infections. Another is the possible relationship between oral microbial communities and oral cancers. The supplied publication list also includes work discussing Fusobacterium nucleatum in carcinogenesis and the potential use of CRISPR-Cas approaches to address antimicrobial resistance. These publications represent complementary perspectives on resistance mechanisms, microbial-host interactions, and emerging research strategies.[3]

  • Antibiotic resistance mechanisms and colistin resistance.
  • Oral microbiome research and potential disease associations.
  • CRISPR-Cas systems as a prospective research direction for antimicrobial resistance.

Publications

The following selected works are based on the bibliographic information supplied for this article. Citation counts can vary between databases and over time.

  1. Aghapour, Z., Gholizadeh, P., Ganbarov, K., et al. (2019). Molecular mechanisms related to colistin resistance in Enterobacteriaceae. Infection and Drug Resistance, 965–975.
  2. Gholizadeh, P., Eslami, H., Yousefi, M., et al. (2016). Role of oral microbiome on oral cancers, a review. Biomedicine & Pharmacotherapy, 84, 552–558.
  3. Gholizadeh, P., Eslami, H., & Kafil, H. S. (2017). Carcinogenesis mechanisms of Fusobacterium nucleatum. Biomedicine & Pharmacotherapy, 89, 918–925.
  4. Gholizadeh, P., Köse, Ş., Dao, S., et al. (2020). How CRISPR-Cas system could be used to combat antimicrobial resistance. Infection and Drug Resistance, 1111–1121.
  5. Gholizadeh, P., Pormohammad, A., Eslami, H., et al. (2017). Oral pathogenesis of Aggregatibacter actinomycetemcomitans. Microbial Pathogenesis, 113, 303–311.

Research Impact

The supplied profile figures report 110 documents, 4,556 citations, and an h-index of 37. These figures suggest a substantial publication and citation record if confirmed against the relevant database profile. They should be treated as user-provided values rather than independently verified statistics. Citation metrics measure particular aspects of scholarly attention and should be interpreted alongside research quality, methodological rigor, reproducibility, and practical relevance.

Award Suitability

The research themes and supplied publication record provide relevant material for consideration in an academic recognition process associated with the International Academic Excellence Awards. A fair assessment should consider verified publications, individual contributions, research quality, and documented impact. This profile does not establish that an award has been granted or that editorial board membership has been independently confirmed.

Conclusion

Pourya Gholizadeh’s selected publications cover important questions in antimicrobial resistance, oral microbiology, and microbial pathogenesis. Together, these topics illustrate connections between fundamental microbiological research and clinical challenges. Verification of bibliographic records, institutional affiliation, research metrics, and editorial role will strengthen the accuracy and reliability of this academic recognition profile.

References

  1. Google Scholar. (n.d.). Pourya Gholizadeh: author profile and publication records. https://scholar.google.com/citations?user=1XSHxVkAAAAJ&hl=en
  2. Gholizadeh, P., Eslami, H., Yousefi, M., et al. (2016). Role of oral microbiome on oral cancers, a review. Biomedicine & Pharmacotherapy, 84, 552–558. Publication record: Google Scholar record. DOI not independently verified.
  3. Aghapour, Z., Gholizadeh, P., Ganbarov, K., et al. (2019). Molecular mechanisms related to colistin resistance in Enterobacteriaceae. Infection and Drug Resistance, 965–975. Publication record: Google Scholar record. DOI not independently verified.
  4. Gholizadeh, P., Eslami, H., & Kafil, H. S. (2017). Carcinogenesis mechanisms of Fusobacterium nucleatum. Biomedicine & Pharmacotherapy, 89, 918–925. Publication record. DOI not independently verified.
  5. Gholizadeh, P., Köse, Ş., Dao, S., et al. (2020). How CRISPR-Cas system could be used to combat antimicrobial resistance. Infection and Drug Resistance, 1111–1121. Publication record. DOI not independently verified.
  6. Gholizadeh, P., Pormohammad, A., Eslami, H., et al. (2017). Oral pathogenesis of Aggregatibacter actinomycetemcomitans. Microbial Pathogenesis, 113, 303–311. Publication record. DOI not independently verified.
  7. International Academic Excellence Awards. (n.d.). Official award website. https://academicexcellenceawards.com/

Ricardo Dario Zwiener | Allergy | Academic Excellence Award

Published on by Academic Excellence

Dr. Ricardo Dario Zwiener | Allergy | Academic Excellence Award

Dr. Ricardo Dario Zwiener, Instituto de inmunoalergia Dr. Zwiener, Argentina

Dr. Ricardo Dario Zwiener is a distinguished physician with over 20 years of experience specializing in Internal Medicine and Clinical Allergology and Immunology. He currently serves as the Medical Director and Head of Research & Education at the Centro de Alergia e Inmunología Dr. Zwiener, as well as a Clinical Allergy and Immunology Department leader at Hospital Universitario Austral. Dr. Zwiener has a passion for research, particularly in Hereditary Angioedema, Severe Asthma, and other allergic conditions. His approach blends evidence-based medicine with a deep commitment to patient care, fostering a collaborative and open dialogue with his patients. As a speaker, educator, and author, he has contributed to numerous publications, becoming a trusted voice in the global allergy and immunology community.

Professional Profile

Scopus

Orcid

Suitability For the Academic Excellence Award

Dr. Ricardo Dario Zwiener is an exemplary candidate for the Research for Academic Excellence Award, given his extensive and impactful contributions to the fields of Internal Medicine, Clinical Allergy, and Immunology. Over the span of his two-decade career, Dr. Zwiener has held pivotal roles in medical leadership, particularly as the Medical Director and Head of Research & Education at the Centro de Alergia e Inmunología Dr. Zwiener. His clinical expertise is reflected in his work at the Hospital Universitario Austral, where he has made significant strides in advancing knowledge on hereditary angioedema, severe asthma, and other immunological disorders.

Dr. Zwiener’s involvement in groundbreaking clinical research, such as his studies on hereditary angioedema (HAE) and severe asthma, underscores his commitment to improving patient outcomes through innovative therapeutic approaches. His participation in high-profile studies, including the Geo Study (Takeda) and the Reveal Study (Sanofi), demonstrates his dedication to evidence-based medicine. His publication record is equally impressive, with contributions to notable journals such as the Journal of Allergy and Clinical Immunology, where he has co-authored pivotal research on chemotherapy-induced anaphylaxis and allergic rhinitis treatment.

🎓 Education

Dr. Zwiener earned his medical degree from the University of Buenos Aires and has pursued advanced specialization in Internal Medicine and Clinical Allergology. His dedication to furthering his medical knowledge is evident in his extensive post-graduate studies and certifications in allergy and immunology. Throughout his career, Dr. Zwiener has been involved in several educational initiatives, both locally and internationally, providing insight into his areas of expertise. He continues to engage in educational programs to ensure that he stays at the forefront of new developments in his field, ensuring that his practice is grounded in the latest medical advances.

💼 Professional Experience

Dr. Ricardo Dario Zwiener has an extensive career spanning two decades in the medical field. He began his journey at Hospital Universitario Austral, where he specialized in Internal Medicine and later transitioned to the Allergy and Immunology Department. Since 2007, he has served as a key member of the Clinical Allergy and Immunology Department at the same hospital. In 2018, Dr. Zwiener founded and became the Medical Director of Centro de Alergia e Inmunología Dr. Zwiener, where he focuses on innovative research and education. His expertise in managing complex allergic conditions, especially hereditary angioedema, has led him to collaborate on various high-profile studies and clinical trials, driving advancements in allergy treatments and patient care.

🏅 Awards and Recognition

Dr. Zwiener has been recognized internationally for his contributions to allergy and immunology. His work in hereditary angioedema and severe asthma has been acknowledged through numerous awards, including the Best Oral Presentation at the 11th C1-Inhibitor Deficiency & Angioedema Workshop in Budapest in 2019. In addition, his research has been cited in renowned journals such as Allergy, Journal of Allergy and Clinical Immunology, and Rev Alerg Mex. His dedication to advancing the field has earned him prestigious distinctions, including recognition for his involvement in the GA2 LEN/HAEi Angioedema Centers of Reference and Excellence project.

🌍 Research Skills On Allergy

Dr. Zwiener’s research is primarily focused on hereditary angioedema, severe asthma, and the immunological aspects of allergic diseases. He has spearheaded multiple clinical trials, including the Geo study for hereditary angioedema and the Reveal Study for severe asthma, aiming to improve diagnosis, treatment, and patient outcomes. His research efforts extend to assessing the incidence and risk factors for chemotherapy-induced anaphylaxis, contributing valuable insights to the allergy and immunology community. His skills in conducting innovative clinical studies, as well as his ability to translate research into practical applications, have solidified his reputation as a leader in the field.

📖 Publication Top Notes

  • Assessing the accuracy of ChatGPT’s responses to common allergy myths
    • Authors: Estrada-Mendizabal, R.J., Cojuc-Konigsberg, G., Labib, E.N., … , Zwiener, R., Canel-Paredes, A.
    • Citation: Journal of Allergy and Clinical Immunology: In Practice, 2024.
    • Citations: 0
  • A concept for integrated care pathways for atopic dermatitis—A GA2LEN ADCARE initiative
    • Authors: Zuberbier, T., Abdul Latiff, A., Aggelidis, X., … , Zwiener, R., Worm, M.
    • Citation: Clinical and Translational Allergy, 2023, 13(9), e12299.
    • Citations: 2
  • COVID-19 triggers attacks in HAE patients without worsening disease outcome
    • Authors: Olivares, M.M., Zwiener, R.D., Panqueva, L.M.L., … , Leyva Barrero, R.R., Grumach, A.S.
    • Citation: Journal of Allergy and Clinical Immunology: In Practice, 2022, 10(3), pp. 855–858.
    • Citations: 8
  • Chemotherapy-induced anaphylaxis and fatal anaphylaxis in the United States: Incidence and risk factors
    • Authors: Bojanini, L., Morgenstern-Kaplan, D., Carrillo-Martin, I., … , Zwiener, R., Gonzalez-Estrada, A.
    • Citation: Clinical and Experimental Allergy, 2021, 51(11), pp. 1514–1518.
    • Citations: 2
  • Treatment of allergic rhinitis in adults in Argentina. Update document
    • Authors: Vazquez, D., Onetti, C.I., Moreno, P., … , Ardusso, L., Fantini, C.
    • Citation: Archivos de Alergia e Inmunologia Clinica, 2021, 52(Supplement 001), pp. 7–36.
    • Citations: 0
  • Consensus on the diagnosis and treatment of hereditary angioedema (HAE) in Argentina
    • Authors: Vazquez, D.O., Josviack, D.O., Fantini, C.A., … , Strass, M.D., Fabiani, J.E.
    • Citation: Archivos de Alergia e Inmunologia Clinica, 2021, 52(Supplement 002), pp. 6–13.
    • Citations: 1
  • Argentine consensus of the diagnosis and treatment of hereditary angioedema
    • Authors: Vazquez, D.O., Josviack, D.O., Fantini, C.A., … , Strass, M.D., Fabiani, J.E.
    • Citation: Revista Alergia Mexico, 2021, 68(6), pp. S1–S22.
    • Citations: 4
  • Severe cutaneous adverse reactions to drugs in Latin America: The RACGRAD study
    • Authors: Rojas Mejía, D.V., Zwiener, R.D., Cardona Villa, R., … , Jares, E., Serrano Reyes, C.D.
    • Citation: Journal of Investigational Allergology and Clinical Immunology, 2021, 31(4), pp. 322–331.
    • Citations: 6
  • Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence
    • Authors: Maurer, M., Aberer, W., Agondi, R., … , Zwiener, R.D., Castaldo, A.
    • Citation: Allergy: European Journal of Allergy and Clinical Immunology, 2020, 75(8), ALL14293.
    • Citations: 36
  • Immunology of Bee Venom
    • Authors: Elieh Ali Komi, D., Shafaghat, F., Zwiener, R.D.
    • Citation: Clinical Reviews in Allergy and Immunology, 2018, 54(3), pp. 386–396.
    • Citations: 71